Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03968315 · ClinicalTrials.gov registry record · NA
An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma
A NA study of Thymoma and Recurrent Malignant Thymoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03968315 is a NA study of Thymoma and Recurrent Malignant Thymoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 40 participants, below the 140-participant average among 9 other Thymoma trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03968315, a NA study of Thymoma and Recurrent Malignant Thymoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies the accuracy of a magnetic resonance imaging (MRI) scan in imaging the inside of the chest in patients with thymoma that is newly diagnosed or has come back. An MRI scan may be able to detect if and how far the tumor has spread more accurately than a standard computed tomography (CT) scan.
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Imaging
- PROCEDURE Diaphragm Fluoroscopy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-06-08 |
| Est. Completion | 2029-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03968315
The ClinicalTrials.gov registry entry for NCT03968315 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 9 other Thymoma trials with a reported enrollment target (71% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Thymoma appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.
NCT03968315 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03968315 about?
NCT03968315 is a clinical study titled "An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma". This trial studies the accuracy of a magnetic resonance imaging (MRI) scan in imaging the inside of the chest in patients with thymoma that is newly diagnosed or has come back. An MRI scan may be able to detect if and how far the tumor has spread more accurately than a standard computed tomography (...
What is the current status of trial NCT03968315?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2011-06-08. Estimated completion is 2029-04-30.
What conditions does trial NCT03968315 study?
This clinical trial studies the following conditions: Thymoma, Recurrent Malignant Thymoma.
What interventions are being tested in trial NCT03968315?
The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Diaphragm Fluoroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT03968315?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03968315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thymoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Clinical Investigation of the da Vinci Surgical System
ACTIVE NOT RECRUITING · NA
-
SP Thoracic IDE Study
ACTIVE NOT RECRUITING · NA
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
-
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
RECRUITING · Phase 2
-
Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma
ACTIVE NOT RECRUITING · Phase 2
-
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.